ARTICLE | Politics, Policy & Law
Pharmas to invest $1 billion in biotechs to fight AMR as bridge to market reforms
AMR Action Fund pushing antibiotic development but pull mechanisms needed urgently
July 10, 2020 1:45 AM UTC
Twenty-three pharmas have banded together to create a $1 billion fund to provide bridges from Phase II to approval for biotechs trying to advance products that combat antimicrobial resistance.
The AMR Action Fund will be a bridge to nowhere unless solutions are implemented for market failures that have bankrupted public biotechs with approved antibiotics and starved the sector of VC funding. ...